Recent

% | $
Quotes you view appear here for quick access.

Vical Incorporated Message Board

avii77 1 post  |  Last Activity: May 27, 2016 8:21 AM Member since: Oct 24, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • avii77 avii77 May 27, 2016 8:21 AM Flag

    "Malik was a London-based analyst for Cenkos, since suspended, then departed after Phase V report."

    Hey Jerry, you should look into this Malik character a bit more.

    Phase 5 suggested his first involvement with NWBO was in 2010 with his 40 page pump piece (that they accuse him of getting paid stock for writing and hiding in his girlfriends name).

    That wasn't his first involvement with NWBO though.

    In 2007 NWBO was listed on the AIM market in the UK and NWBO raised $26 million. A few weeks after the listing came the infamous "Swiss Approval". Malik pumped the hell out of that Swiss Approval" and the stock tripled. Collins Stewart was the Nominated Advisor for the AIM listing. Guess who was at Collins Stewart handling the NWBO listing?

    Linda issued a PR denying "certain" allegations that she sold stock in that BS Swiss Approval pump.

    She may not have sold stock, but that's about the time when she made the "oral arrangement" with herself to lease space for $30k+/month to house 4 employees.

    "Previously, we had been occupying our Bethesda headquarters under an oral arrangement with Toucan Capital Corporation, whereby we were required to pay base rent of $32,949 per month through December 31, 2007."

    How much of that $26 million found its' way into Linda's pocket? She's on record as saying it would only cost $10 million to run the DCVax brain trial.

    Would you think that Malik, a UK based biotech expert, would know something about the veracity of the Swiss approval? Since he was the nominated advisor and broker for the AIM listing, do you think he would know that NWBO never even applied for marketing authorization?

    And what about the lucky foreign investors who bought that $26 million in NWBO on the AIM market? They saw their investment spike 350% 2 weeks later with the bogus Swiss Approval news.

    Nah, I'm sure the investigation will clear all this up. Just an unlucky series of coincidences- part of Big Pharma's conspiracy.

VICL
4.47-0.13(-2.83%)Jun 24 4:00 PMEDT